Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin vs Methylphenidate in ADHD with Sleep Difficulties
NCT01393574Phase 4Unknown
- Sponsor
- Shamir Medical Center
- Start
- Jun 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of melatonin in attention deficit hyperactivity disorder (ADHD), sponsored by Shamir Medical Center. Status: unknown.
02
Drugs
melatonin
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01393574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393574.